Alyeska Investment Group
SLS icon

Alyeska Investment Group’s SELLAS Life Sciences SLS Stock Holding History

Alyeska Investment Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,479,067
Closed -$1.76M – 672
2024
Q2 		$1.76M Buy
1,479,067
+479,067
+48% +$652K 0.01% 421
2024
Q1 		$1.01M Sell
1,000,000
-275,000
-22% -$231K 0.01% 412
2023
Q4 		$1.35M Buy
1,275,000
+275,000
+28% +$298K 0.01% 394
2023
Q3 		$1.64M Sell
1,000,000
-275,000
-22% -$434K 0.01% 396
2023
Q2 		$2M Buy
1,275,000
+275,000
+28% +$442K 0.01% 409
2023
Q1 		$1.43M Buy
+1,000,000
New +$2.47M 0.01% 376
2020
Q1 		– Sell
-62,500
Closed -$269K – 462
2019
Q4 		$269K Buy
62,500
+61,250
+4,900% +$330K ﹤0.01% 377
2019
Q3 		$8K Hold
1,250
– – ﹤0.01% 393
2019
Q2 		$7K Hold
1,250
– – ﹤0.01% 427
2019
Q1 		$64K Hold
1,250
– – ﹤0.01% 366
2018
Q4 		$77K Hold
1,250
– – ﹤0.01% 353
2018
Q3 		$76K Sell
1,250
-165
-12% -$11.4K ﹤0.01% 399
2018
Q2 		$242K Hold
1,415
– – ﹤0.01% 438
2018
Q1 		$244K Buy
1,415
+1,368
+2,911% +$391K ﹤0.01% 429
2017
Q4 		$556K Sell
47
-6
-11% -$2.9K ﹤0.01% 407
2017
Q3 		$28K Hold
53
– – ﹤0.01% 453
2017
Q2 		$46K Hold
53
– – ﹤0.01% 446
2017
Q1 		$48K Hold
53
– – ﹤0.01% 466
2016
Q4 		$154K Buy
+53
New +$308K ﹤0.01% 458

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Alyeska Investment Group's SLS Position: Q4 2023 in Review

Alyeska Investment Group sold out of SELLAS Life Sciences (SLS) in Q4 2023, closing a stake of 640,011 shares — an estimated $693K sold.

Alyeska Investment Group first reported a position in SLS in Q2 2022 and held it in 4 quarters. The position peaked at $1.96M in Q2 2023. 31 funds tracked by Wall St. Rank hold SLS as of Q4 2023.

  • Alyeska Investment Group reported no remaining SELLAS Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 640,011 SELLAS Life Sciences shares in Q4 2023, an estimated $693K.
  • Alyeska Investment Group first reported a position in SELLAS Life Sciences in Q2 2022 and held it in 4 quarters.
  • Alyeska Investment Group's SELLAS Life Sciences position peaked at $1.96M in Q2 2023.
  • 31 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.